DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAFoundation

Transient ischaemic attack

Essential points for quick revision.

Synopsis

Recognise a suspected transient ischaemic attack, start safe immediate treatment, and arrange rapid specialist assessment without false reassurance from symptom resolution or a risk score.

  • A TIA is a transient focal neurological syndrome caused by cerebral, spinal or retinal ischaemia without acute infarction; the diagnosis remains clinical and retrospective rather than being proved by one normal scan.
  • Sudden negative symptoms such as unilateral weakness, language disturbance or monocular visual loss fit better than gradually spreading positive tingling, flashing lights or jerking, although atypical presentations still need expert assessment.
  • Treat suspected TIA as an urgent warning of stroke: give aspirin 300 mg immediately unless contraindicated and arrange specialist assessment within 24 hours under current NICE guidance.

Key red flags

Any neurological deficit still present, even if improving, requires emergency acute-stroke assessment and immediate brain imaging rather than a TIA clinic appointment.

Investigation priorities

01
Capillary blood glucoseFirst step

Identify a rapidly reversible mimic during or immediately after the focal episode.

Management branches

NOWSuspected resolved TIA

A patient reports a sudden focal neurological or monocular visual deficit that has now completely resolved.

  1. Confirm that no deficit remains, record last-known-well and symptom chronology, check glucose and observations, and seek emergency help if symptoms recur during assessment.
  2. Give aspirin 300 mg immediately unless allergy, active bleeding, current anticoagulation or another important contraindication requires urgent specialist advice.

Key medicines

AspirinGive 300 mg orally once immediately for suspected TIA unless contraindicated, then continue 300 mg daily until specialist review under the local pathway.
ClopidogrelFor established long-term non-cardioembolic secondary prevention, 75 mg orally once daily is commonly selected after specialist confirmation; loading or dual therapy follows a stroke protocol.
Open full textbook Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom